<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38243167</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Effective partnership and in-country resource mobilization in Sudan for cVDPV2 outbreak response amid multiple emergencies in 2020-2021.</ArticleTitle><Pagination><StartPage>235</StartPage><MedlinePgn>235</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">235</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-15675-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">During 2020 and immediately prior to the COVID-19 pandemic, Sudan was experiencing multiple emergencies including violence, seasonal flooding, and vector-borne disease outbreaks. After more than ten years since its last case of wild poliovirus, Sudan declared a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak on 9 August 2020.</AbstractText><AbstractText Label="METHODS">cVDPV2 outbreak response data and programme documents of the Federal Ministry of Health and WHO were reviewed. Surveillance data was verified through WHO-recommended procedures for detecting and characterizing polioviruses from stool and sewage samples collected from acute flaccid paralysis (AFP) cases and the environment.</AbstractText><AbstractText Label="RESULTS">This outbreak in Sudan led to a total of 58 confirmed cases of cVDPV2 from 15 of the 18 states. Two nationwide vaccination campaigns were held to increase immunity of children under-five against poliovirus type 2. Funding challenges were overcome by intense additional resource mobilization from in-country sources. The funding gap was bridged from domestic resources (49%) sourced through GPEI partners, and in-country humanitarian funding mechanisms.</AbstractText><AbstractText Label="CONCLUSIONS">During an outbreak response and challenge of funding shortfall, mobilizing in-country resources is possible through coordinated approaches, regular communication with partners, disaggregation of needs, and matching in-kind and financial support to fill gaps. A cVDPV2 outbreak requires a fast, resourced, and quality response to stop virus circulation.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mashal</LastName><ForeName>Mohammed Taufiq</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Polio and Immunization Programmes, Sudan Country Office, World Health Organization, Khartoum, 2234, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltayeb</LastName><ForeName>Dalya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Federal Ministry of Health, Khartoum, 2234, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins-Steele</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Polio Eradication Department, Eastern Mediterranean Regional Office, World Health Organization, P.O. Box 811547, Mohammad Jamjoum Street, Ministry of Interior Building #5, Amman, 11181, Jordan. higginssteelea@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Sheikh</LastName><ForeName>Ismael Suleiman</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Expanded Programme on Immunization (EPI), Federal Ministry of Health, Khartoum, 2234, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Ni'ma Saeed</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>World Health Organization, Sudan Country Office, Khartoum, 2234, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Hemant</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Polio Eradication Department, Eastern Mediterranean Regional Office, World Health Organization, P.O. Box 811547, Mohammad Jamjoum Street, Ministry of Interior Building #5, Amman, 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Polio Eradication Department, Eastern Mediterranean Regional Office, World Health Organization, P.O. Box 811547, Mohammad Jamjoum Street, Ministry of Interior Building #5, Amman, 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafari</LastName><ForeName>Hamid</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Polio Eradication Department, Eastern Mediterranean Regional Office, World Health Organization, P.O. Box 811547, Mohammad Jamjoum Street, Ministry of Interior Building #5, Amman, 11181, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013397" MajorTopicYN="N" Type="Geographic">Sudan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Domestic resource mobilization</Keyword><Keyword MajorTopicYN="N">Emergencies</Keyword><Keyword MajorTopicYN="N">Partnership</Keyword><Keyword MajorTopicYN="N">Poliovirus eradication</Keyword><Keyword MajorTopicYN="N">Sudan</Keyword><Keyword MajorTopicYN="N">cVDPV2 outbreak</Keyword></KeywordList><CoiStatement>The authors declare there is no conflict of interest for this paper. We do not have a commercial or other association that would pose a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38243167</ArticleId><ArticleId IdType="pmc">PMC10799533</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-15675-y</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-15675-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thompson KM. Poliovirus vaccine options: another step forward. The Lancet. 2020;397:2–3. doi: 10.1016/S0140-6736(20)32629-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32629-5</ArticleId><ArticleId IdType="pubmed">33308426</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691–9. doi: 10.15585/mmwr.mm7049a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7049a1</ArticleId><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 14th meeting of the Global Commission for Certification of Poliomyelitis Eradication (GCC), Bali, Indonesia. Sept 20–21., 2015. Summary of findings, decisions and recommendations. https://polioeradication.org/wp-content/uploads/2016/07/1Report.pdf. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine— worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–38. doi: 10.15585/mmwr.mm6535a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6535a3</ArticleId><ArticleId IdType="pubmed">27606675</ArticleId></ArticleIdList></Reference><Reference><Citation>Macklin GR, O’Reilly KM, Grassly NC, et al. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 2020;368:401–05. doi: 10.1126/science.aba1238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba1238</ArticleId><ArticleId IdType="pmc">PMC10805349</ArticleId><ArticleId IdType="pubmed">32193361</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Global polio eradication set back by COVID-19 pandemic. The Lancet Microbe. 2022;3(3):E172. doi: 10.1016/S2666-5247(22)00042-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00042-8</ArticleId><ArticleId IdType="pmc">PMC8890765</ArticleId><ArticleId IdType="pubmed">35261994</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kew OM, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 2006;26:1471–505. doi: 10.1111/j.1539-6924.2006.00827.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1539-6924.2006.00827.x</ArticleId><ArticleId IdType="pubmed">17184393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper LV, Bandyopadhay AS, Gumede N, et al. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. The Lancet Infect Dis. 2022;22(2):284–94. doi: 10.1016/S1473-3099(21)00453-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00453-9</ArticleId><ArticleId IdType="pmc">PMC8799632</ArticleId><ArticleId IdType="pubmed">34648733</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication initiative, circulating Vaccine Derived Poliovirus. https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>Sudan Polio GPEI. Outbreak 2009. https://reliefweb.int/report/sudan/sudan-polio-outbreak-situation-7-apr-2009. Accessed 30 March 2023.</Citation></Reference><Reference><Citation>WHO. Progress in interrupting wild poliovirus circulation in countries with re-established transmission: Africa, 2009–2010. Weekly Epidemiological Record. 2011. https://apps.who.int/iris/bitstream/handle/10665/241729/WER8612_104-112.PDF. Accessed 30 March 2023.</Citation></Reference><Reference><Citation>CDC Wild poliovirus type 1 and 3 importations - - - 15 countries, Africa, 2008–2009. MMWR Wkly. 2009;58(14):357–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">19373195</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuma J, Wilkinson AL, Diop OM, et al. Surveillance to track progress towards eradication worldwide, 2019–2020. MMWR. 2021;70(18):667–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368747</ArticleId><ArticleId IdType="pubmed">33956779</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI Standard Operating Procedures for Responding to a Poliovirus Outbreak 4.0. 2022. https://polioeradication.org/wp-content/uploads/2022/07/Standard-Operating-Procedures-For-Responding-to-a-Poliovirus-Event-Or-Outbreak-20220807-EN-Final.pdf. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>Eltayeb EM, Haithami SS, El Sayed EA. Combating an outbreak of poliomyelitis in Sudan following wild poliovirus importation: a success story. Sud J Public Health. 2006;1(2):135–8.</Citation></Reference><Reference><Citation>Sudan Health Cluster Annual Report., 2020 Health Response. https://reliefweb.int/sites/reliefweb.int/files/resources/sudan_health_cluster_annual_report_-_2020_response_%20%281%29.pdf. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>Federal Ministry of Health Sudan and WHO COVID-19 dashboard. https://worldhealthorg.shinyapps.io/Outbreaks/. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>WHO. Circulating Poliovirus type 2-Sudan 01. September 2020. https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-sudan. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>World Health Organization, Emergency Response, Framework. 2017. 2nd ed. Geneva. https://apps.who.int/iris/rest/bitstreams/1087191/retrieve. Accessed 29 March 2023.</Citation></Reference><Reference><Citation>Pirio GA, Kaufmann J. Polio eradication is just over the horizon: the challenges of global resource mobilization. J Health Commun. 2010;15(suppl 1):66–83. doi: 10.1080/10810731003695383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10810731003695383</ArticleId><ArticleId IdType="pubmed">20455167</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Kalkowska DA, Badizadegan K. Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the global Polio Eradication Initiative. Gates Open Res. 2022;6:5. doi: 10.12688/gatesopenres.13524.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.13524.1</ArticleId><ArticleId IdType="pmc">PMC8881365</ArticleId><ArticleId IdType="pubmed">35280345</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI. Delivering on a promise, Polio Eradication Strategy 2022–2026. https://polioeradication.org/gpei-strategy2022-2026/. Accessed 4 Sept 2022.</Citation></Reference><Reference><Citation>Mohammed A, Tomori O, Nkengosong JN. Lessons from the elimination of poliomyelitis in Africa. Nat Reviews Imm. 2021;21:823–8. doi: 10.1038/s41577-021-00640-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00640-w</ArticleId><ArticleId IdType="pmc">PMC8544186</ArticleId><ArticleId IdType="pubmed">34697501</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunization agenda. 2030. A global strategy to leave no one behind. https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030. Accessed 4 Sept 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">39004466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>